FDA Adverse Event Malfunction Summary report: N

CHOLESTEROL GEN.2

MDR report key: 22326945 · Received June 25, 2025

Report

Report Number
1823260-2025-01940
Event Type
Malfunction
Date Received
June 25, 2025
Date of Event
May 31, 2025
Report Date
July 30, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CHH
UDI-DI
04015630918430
PMA / PMN Number
K031824
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TC
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INTEGRA 400 PLUS SERIAL NUMBER WAS (B)(6). CALIBRATION AND QC WERE ACCEPTABLE. PRECISION RESULTS WERE WITHIN SPECIFICATION. THE CUSTOMER REPEATED OTHER PATIENT SAMPLES TESTED FOR CHOL2 ON 30-MAY-2025, 31-MAY-2025, AND 01-JUN-2025, AND THE RESULTS WERE REPRODUCIBLE.

Additional Manufacturer Narrative · 0

THE CUSTOMER DID NOT PROVIDE ANY ADDITIONAL INFORMATION FOR THE INVESTIGATION. A GENERAL REAGENT PROBLEM WAS EXCLUDED AS CALIBRATION AND QC WERE ACCEPTABLE. BASED ON THE INFORMATION PROVIDED, THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF DISCREPANT RESULTS FOR 1 PATIENT SAMPLE TESTED FOR CHOLESTEROL GEN.2 (CHOL2) ON A COBAS INTEGRA 400 PLUS ANALYZER. THE INITIAL RESULT WAS 15.49 MMOL/L. ON 02-JUN-2025, A NEW SAMPLE WAS OBTAINED, AND THE RESULT WAS 5.44 MMOL/L. THE ORIGINAL SAMPLE WAS REPEATED WITH A RESULT OF 5.72 MMOL/L.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2361012 CHOLESTEROL GEN.2 ENZYMATIC ESTERASE--OXIDASE, CHOLESTEROL CHH ROCHE DIAGNOSTICS 836489 04015630918430

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown